Nitric oxide donors as neuroprotective agents after an ischemic stroke-related inflammatory reaction

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Godínez Rubí, Marisol ^a   Rojas Mayorquín, Argelia E ^a,b   Ortuño Sahagún, Daniel ^a  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

^b INSTITUTO NACIONAL DE GERIATRÍA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE ISCHEMIC STROKE; CEREBRAL ISCHEMIA-REPERFUSION; INFLAMMATORY REACTION; INFLAMMATORY RESPONSE; INTRACELLULAR CALCIUM; NEUROPROTECTIVE AGENTS; REACTIVE OXYGEN SPECIES; THERAPEUTIC SOLUTIONS;

BRAIN; NITRIC OXIDE;

OXIDATIVE STRESS;

CALCIUM ION; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLYCERYL TRINITRATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; ISOSORBIDE 5 NITRATE; JANUS KINASE 3; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MOLSIDOMINE; N ACETYL S NITROSOPENICILLAMINE; NEURONAL NITRIC OXIDE SYNTHASE; NICORANDIL; NITRIC ACID DERIVATIVE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; PENTAERYTHRITYL TETRANITRATE; PROTEIN BAD; PROTEIN KINASE B; REACTIVE NITROGEN SPECIES; S NITROSOGLUTATHIONE; S NITROSOTHIOL; SODIUM NITRITE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZJM 289; NEUROPROTECTIVE AGENT;

ALTERNATIVE MEDICINE; ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ASTROCYTE; ATTENUATION; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; BRAIN INFARCTION; BRAIN ISCHEMIA; CENTRAL NERVOUS SYSTEM; CYTOKINE PRODUCTION; DEGENERATIVE DISEASE; DRUG EFFICACY; EXCITOTOXICITY; HUMAN; INFLAMMATION; MICROGLIA; NERVE CELL; NEUROPROTECTION; NEUROSURGERY; NITROSATIVE STRESS; NITROSYLATION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHARMACODYNAMICS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; REPERFUSION INJURY; REVIEW; RISK REDUCTION; THROMBOCYTE AGGREGATION; ANIMAL; CEREBROVASCULAR ACCIDENT;

ANIMALS; BRAIN ISCHEMIA; HUMANS; INFLAMMATION; NEUROPROTECTIVE AGENTS; NITRIC OXIDE DONORS; REPERFUSION INJURY; STROKE;

EID: 84877264632     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/297357     Document Type: Review

References (175)

1. Lakhan S. E., Kirchgessner A., Hofer M., Inflammatory mechanisms in ischemic stroke: therapeutic approaches. Journal of Translational Medicine 2009 7, article 97 2-s2.0-71049180369 10.1186/1479-5876-7-97
2. Lo E. H., Dalkara T., Moskowitz M. A., Mechanisms, challenges and opportunities in stroke. Nature Reviews Neuroscience 2003 4 5 399 415 2-s2.0-0037868093 10.1038/nrn1106 (Pubitemid 37280178)
3. Iadecola C., Neurovascular regulation in the normal brain and in Alzheimer's disease. Nature Reviews Neuroscience 2004 5 5 347 360 2-s2.0-2342614850 (Pubitemid 38568496)
4. del Zoppo G. J., Stroke and neurovascular protection. The New England Journal of Medicine 2006 354 6 553 555 2-s2.0-32144461723 10.1056/NEJMp058312 (Pubitemid 43209102)
5. Lok J., Gupta P., Guo S., Kim W. J., Whalen M. J., Van Leyen K., Lo E. H., Cell-cell signaling in the neurovascular unit. Neurochemical Research 2007 32 12 2032 2045 2-s2.0-35848949798 10.1007/s11064-007-9342-9 (Pubitemid 350059847)
6. Lu D., Maulik N., Moraru I. I., Kreutzer D. L., Das D. K., Molecular adaptation of vascular endothelial cells to oxidative stress. The American Journal of Physiology 1993 264 3, part 1 C715 C722 2-s2.0-0027476515 (Pubitemid 23103934)
7. Lee B. J., Egi Y., van Leyen K., Lo E. H., Arai K., Edaravone, a free radical scavenger, protects components of the neurovascular unit against oxidative stress in vitro. Brain Research 2010 1307 22 27 2-s2.0-70749150769 10.1016/j.brainres.2009.10.026
8. Warner D. S., Sheng H., Batinić-Haberle I., Oxidants, antioxidants and the ischemic brain. The Journal of Experimental Biology 2004 207 18 3221 3231 2-s2.0-4644360633 10.1242/jeb.01022 (Pubitemid 39275296)
9. Syntichaki P., Tavernarakis N., The biochemistry of neuronal necrosis: rogue biology? Nature Reviews Neuroscience 2003 4 8 672 684 2-s2.0-0043238675 10.1038/nrn1174 (Pubitemid 37280162)
10. Mehta S. L., Manhas N., Raghubir R., Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Research Reviews 2007 54 1 34 66 2-s2.0-33947628060 10.1016/j.brainresrev.2006.11.003 (Pubitemid 46498164)
11. Lin M. T., Beal M. F., Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006 443 7113 787 795 2-s2.0-33750347347 10.1038/nature05292 (Pubitemid 44622683)
12. Gandhi S., Abramov A. Y., Mechanism of oxidative stress in neurodegeneration. Oxidative Medicine and Cellular Longevity 2012 2012 11 428010 10.1155/2012/428010
13. Davies K. J., Oxidative stress: the paradox of aerobic life. Biochemical Society Symposium 1995 61 1 31 2-s2.0-0029439509
14. Mastaloudis A., Leonard S. W., Traber M. G., Oxidative stress in athletes during extreme endurance exercise. Free Radical Biology & Medicine 2001 31 7 911 922 2-s2.0-0035478983 10.1016/S0891-5849(01)00667-0 (Pubitemid 32925089)
15. Shi H., Liu K. J., Cerebral tissue oxygenation and oxidative brain injury during ischemia and reperfusion. Frontiers in Bioscience 2007 12 4 1318 1328 2-s2.0-34248995460 10.2741/2150 (Pubitemid 46846837)
16. Broughton B. R. S., Reutens D. C., Sobey C. G., Apoptotic mechanisms after cerebral ischemia. Stroke 2009 40 5 e331 e339 2-s2.0-65549098614 10.1161/STROKEAHA.108.531632
17. Barber P. A., Demchuk A. M., Hirt L., Buchan A. M., Biochemistry of ischemic stroke. Advances in Neurology 2003 92 151 164 2-s2.0-0037795231
18. Drexler H., Hornig B., Endothelial dysfunction in human disease. Journal of Molecular and Cellular Cardiology 1999 31 1 51 60 2-s2.0-0032990560 10.1006/jmcc.1998.0843 (Pubitemid 29078218)
19. Cai H., Harrison D. G., Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circulation Research 2000 87 10 840 844 2-s2.0-0034634281
20. Niizuma K., Endo H., Chan P. H., Oxidative stress and mitochondrial dysfunction as determinants of ischemic neuronal death and survival. Journal of Neurochemistry 2009 109 supplement 1 133 138 2-s2.0-64349101903 10.1111/j.1471-4159.2009.05897.x
21. Ahmad M., Graham S. H., Inflammation after stroke: mechanisms and therapeutic approaches. Translational Stroke Research 2010 1 2 74 84 2-s2.0-77955850207 10.1007/s12975-010-0023-7
22. Wong C. H. Y., Crack P. J., Modulation of neuro-inflammation and vascular response by oxidative stress following cerebral ischemia-reperfusion injury. Current Medicinal Chemistry 2008 15 1 1 14 2-s2.0-39049169272 10.2174/092986708783330665 (Pubitemid 351234624)
23. Beer C., Blacker D., Hankey G. J., Puddey I. B., Association of clinical and aetiologic subtype of acute ischaemic stroke with inflammation, oxidative stress and vascular function: a cross-sectional observational study. Medical Science Monitor 2011 17 9 467 473
24. Pandya R. S., Mao L., Zhou H., Zhou S., Zeng J., Popp A. J., Wang X., Central nervous system agents for ischemic stroke: neuroprotection mechanisms. Central Nervous System Agents in Medicinal Chemistry 2011 11 2 81 97 2-s2.0-79959315559
25. Schnegg C. I., Robbins M. E., Neuroprotective mechanisms of PPAR δ: modulation of oxidative stress and inflammatory processes. PPAR Research 2011 2011 10 373560 10.1155/2011/373560
26. Ceulemans A. G., Zgavc T., Kooijman R., Hachimi-Idrissi S., Sarre S., Michotte Y., The dual role of the neuroinflammatory response after ischemic stroke: modulatory effects of hypothermia. Journal of Neuroinflammation 2010 7, article 74 2-s2.0-78549247765 10.1186/1742-2094-7-74
27. Downes C. E., Crack P. J., Neural injury following stroke: are Toll-like receptors the link between the immune system and the CNS? British Journal of Pharmacology 2010 160 8 1872 1888 2-s2.0-77954884148 10.1111/j.1476-5381.2010. 00864.x
28. Zierath D., Thullbery M., Hadwin J., Gee J. M., Savos A., Kalil A., Becker K. J., CNS immune responses following experimental stroke. Neurocritical Care 2010 12 2 274 284 2-s2.0-77953612092 10.1007/s12028-009-9270-4
29. Turrin N. P., Rivest S., Tumor necrosis factor α but not interleukin 1 β mediates neuroprotection in response to acute nitric oxide excitotoxicity. The Journal of Neuroscience 2006 26 1 143 151 2-s2.0-30644480429 10.1523/JNEUROSCI.4032-05.2006 (Pubitemid 43089527)
30. Stoll G., Jander S., Schroeter M., Detrimental and beneficial effects of injury-induced inflammation and cytokine expression in the nervous system. Advances in Experimental Medicine and Biology 2002 513 87 113 2-s2.0-0036935538 (Pubitemid 36332404)
31. Fontaine V., Mohand-Said S., Hanoteau N., Fuchs C., Pfizenmaier K., Eisel U., Neurodegenerative and neuroprotective effects of tumor Necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2. The Journal of Neuroscience 2002 22 7 RC216 2-s2.0-0036548875
32. Stoll G., Jander S., Schroeter M., Cytokines in CNS disorders: neurotoxicity versus neuroprotection. Journal of Neural Transmission, Supplement 2000 59 81 89 2-s2.0-0033624408 (Pubitemid 30479409)
33. Lo E. H., Combination stroke therapy: easy as APC? Nature Medicine 2004 10 12 1295 1296 (Pubitemid 40022706)
34. Fagan S. C., Hess D. C., Machado L. S., Hohnadel E. J., Pollock D. M., Ergul A., Tactics for vascular protection after acute ischemic stroke. Pharmacotherapy 2005 25 3 387 395 2-s2.0-14544276825 10.1592/phco.25.3.387.61592 (Pubitemid 40300326)
35. Cirino G., Fiorucci S., Sessa W. C., Endothelial nitric oxide synthase: the cinderella of inflammation? Trends in Pharmacological Sciences 2003 24 2 91 95 2-s2.0-0037304922 10.1016/S0165-6147(02)00049-4 (Pubitemid 36135883)
36. Cirino G., Distrutti E., Wallace J. L., Nitric oxide and inflammation. Inflammation & Allergy-Drug Targets 2006 5 2 115 119 2-s2.0-33744501514 10.2174/187152806776383143 (Pubitemid 43796673)
37. Rodrigo J., Fernández A. P., Serrano J., Peinado M. A., Martínez A., The role of free radicals in cerebral hypoxia and ischemia. Free Radical Biology & Medicine 2005 39 1 26 50 2-s2.0-19644364808 10.1016/j.freeradbiomed.2005.02.010 (Pubitemid 40740221)
38. Khan M., Jatana M., Elango C., Paintlia A. S., Singh A. K., Singh I., Cerebrovascular protection by various nitric oxide donors in rats after experimental stroke. Nitric Oxide 2006 15 2 114 124 2-s2.0-33746861531 10.1016/j.niox.2006.01.008 (Pubitemid 44175884)
39. Iadecola C., Bright and dark sides of nitric oxide in ischemic brain injury. Trends in Neurosciences 1997 20 3 132 139 2-s2.0-0031020172 10.1016/S0166-2236(96)10074-6 (Pubitemid 27086729)
40. Guix F. X., Uribesalgo I., Coma M., Muñoz F. J., The physiology and pathophysiology of nitric oxide in the brain. Progress in Neurobiology 2005 76 2 126 152 2-s2.0-24144494527 10.1016/j.pneurobio.2005.06.001 (Pubitemid 41242885)
41. Adachi N., Lei B., Soutani M., Arai T., Different roles of neuronal and endothelial nitric oxide synthases on ischemic nitric oxide production in gerbil striatum. Neuroscience Letters 2000 288 2 151 154 2-s2.0-0034648104 10.1016/S0304-3940(00)01222-2 (Pubitemid 30392433)
42. Iadecola C., Zhang F., Casey R., Nagayama M., Ross M. E., Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. The Journal of Neuroscience 1997 17 23 9157 9164 2-s2.0-0030664096 (Pubitemid 27498443)
43. Stanarius A., Töpel I., Schulz S., Noack H., Wolf G., Immunocytochemistry of endothelial nitric oxide synthase in the rat brain: a light and electron microscopical study using the tyramide signal amplification technique. Acta Histochemica 1997 99 4 411 429 2-s2.0-0342437100 (Pubitemid 27515189)
44. Kuhlencordt P. J., Rosel E., Gerszten R. E., Morales-Ruiz M., Dombkowski D., Aikinson W. J., Han F., Preffer F., Rosenzweig A., Sessa W. C., Gimbrone M. A., Ertl G., Huang P. L., Role of endothelial nitric oxide synthase in endothelial activation: insights from eNOS knockout endothelial cells. The American Journal of Physiology 2004 286 5 C1195 C1202 2-s2.0-11144355166 10.1152/ajpcell.00546.2002 (Pubitemid 38506935)
45. Abu Nabah Y. N., Mateo T., Cerdá-Nicolás M., L-NAME induces direct arteriolar leukocytes adhesion, which is mainly mediated by angiotensin-II. Microcirculation 2005 12 5 443 453 2-s2.0-23744506248 10.1080/10739680590960962 (Pubitemid 41122468)
46. Moore C., Sanz-Rosa D., Emerson M., Distinct role and location of the endothelial isoform of nitric oxide synthase in regulating platelet aggregation in males and females in vivo. European Journal of Pharmacology 2011 651 1-3 152 158 2-s2.0-78650679530 10.1016/j.ejphar.2010.11.011
47. Hossain M., Qadri S. M., Liu L., Inhibition of nitric oxide synthesis enhances leukocyte rolling and adhesion in human microvasculature. Journal of Inflammation 2012 9, article 28
48. Ito Y., Ohkubo T., Asano Y., Hattori K., Shimazu T., Yamazato M., Nagoya H., Kato Y., Araki N., Nitric oxide production during cerebral ischemia and reperfusion in eNOS- and nNOS-knockout mice. Current Neurovascular Research 2010 7 1 23 31 2-s2.0-77949733963 10.2174/156720210790820190
49. Liu K., Li Q., Zhang L., Zheng X., The dynamic detection of NO during stroke and reperfusion in vivo. Brain Injury 2009 23 5 450 458 2-s2.0-67650513895 10.1080/02699050902838173
50. Zhou L., Zhu D. Y., Neuronal nitric oxide synthase: structure, subcellular localization, regulation, and clinical implications. Nitric Oxide 2009 20 4 223 230 2-s2.0-67349230279 10.1016/j.niox.2009.03.001
51. Wei G., Dawson V. L., Zweier J. L., Role of neuronal and endothelial nitric oxide synthase in nitric oxide generation in the brain following cerebral ischemia. Biochimica et Biophysica Acta 1999 1455 1 23 34 2-s2.0-0032782417 10.1016/S0925-4439(99)00051-4 (Pubitemid 29397486)
52. Iadecola C., Zhang F., Xu X., Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage. The American Journal of Physiology 1995 268 1 R286 R292 2-s2.0-0028891572
53. Khan M., Sekhon B., Giri S., Jatana M., Gilg A. G., Ayasolla K., Elango C., Singh A. K., Singh I., S-Nitrosoglutathione reduces inflammation and protects brain against focal cerebral ischemia in a rat model of experimental stroke. Journal of Cerebral Blood Flow and Metabolism 2005 25 2 177 192 2-s2.0-12844264783 10.1038/sj.jcbfm.9600012 (Pubitemid 40171200)
54. Gibson C. L., Coughlan T. C., Murphy S. P., Glial nitric oxide and ischemia. GLIA 2005 50 4 417 426 2-s2.0-20344392918 10.1002/glia.20143 (Pubitemid 40780845)
55. Niwa M., Inao S., Takayasu M., Kawai T., Kajita Y., Nihashi T., Kabeya R., Sugimoto T., Yoshida J., Asano T., Tada T., Time course of expression of three nitric oxide synthase isoforms after transient middle cerebral artery occlusion in rats. Neurologia Medico-Chirurgica 2001 41 2 63 73 2-s2.0-0035086889 10.2176/nmc.41.63 (Pubitemid 32230395)
56. Suzuki M., Tabuchi M., Ikeda M., Tomita T., Concurrent formation of peroxynitrite with the expression of inducible nitric oxide synthase in the brain during middle cerebral artery occlusion and reperfusion in rats. Brain Research 2002 951 1 113 120 2-s2.0-0037183765 10.1016/S0006-8993(02)03145-1 (Pubitemid 35253904)
57. Pannu R., Singh I., Pharmacological strategies for the regulation of inducible nitric oxide synthase: neurodegenerative versus neuroprotective mechanisms. Neurochemistry International 2006 49 2 170 182 2-s2.0-33744984393 10.1016/j.neuint.2006.04.010 (Pubitemid 43867075)
58. Huang Z., Huang P. L., Ma J., Meng W., Ayata C., Fishman M. C., Moskowitz M. A., Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine. Journal of Cerebral Blood Flow and Metabolism 1996 16 5 981 987 2-s2.0-0029780767 (Pubitemid 26292066)
59. Li R., Guo M., Zhang G., Xu X., Li Q., Nicotiflorin reduces cerebral ischemic damage and upregulates endothelial nitric oxide synthase in primarily cultured rat cerebral blood vessel endothelial cells. Journal of Ethnopharmacology 2006 107 1 143 150 2-s2.0-33745862382 10.1016/j.jep.2006.04. 024 (Pubitemid 44038823)
60. Hara H., Huang P. L., Panahian N., Fishman M. C., Moskowitz M. A., Reduced brain edema and infarction volume in mice lacking the neuronal isoform of nitric oxide synthase after transient MCA occlusion. Journal of Cerebral Blood Flow and Metabolism 1996 16 4 605 611 2-s2.0-0029976959 (Pubitemid 26227069)
61. Pei D.-S., Song Y.-J., Yu H.-M., Hu W.-W., Du Y., Zhang G.-Y., Exogenous nitric oxide negatively regulates c-Jun N-terminal kinase activation via inhibiting endogenous NO-induced S-nitrosylation during cerebral ischemia and reperfusion in rat hippocampus. Journal of Neurochemistry 2008 106 4 1952 1963 2-s2.0-48749124859 10.1111/j.1471-4159.2008.05531.x
62. Nanri K., Montécot C., Springhetti V., Seylaz J., Pinard E., The selective inhibitor of neuronal nitric oxide synthase, 7- nitroindazole, reduces the delayed neuronal damage due to forebrain ischemia in rats. Stroke 1998 29 6 1248 1254 2-s2.0-0344813701 (Pubitemid 28265484)
63. Gürsoy-Özdemir Y., Bolay H., Saribaş O., Dalkara T., Role of endothelial nitric oxide generation and peroxynitrite formation in reperfusion injury after focal cerebral ischemia. Stroke 2000 31 8 1974 1981 2-s2.0-0033858805 (Pubitemid 30620482)
64. Sun M., Zhao Y., Gu Y., Xu C., Inhibition of nNOS reduces ischemic cell death through down-regulating calpain and caspase-3 after experimental stroke. Neurochemistry International 2009 54 5-6 339 346 2-s2.0-61449215012 10.1016/j.neuint.2008.12.017
65. Yu H. M., Xu J., Li C., Zhou C., Zhang F., Han D., Zhang G. Y., Coupling between neuronal nitric oxide synthase and glutamate receptor 6-mediated c-Jun N-terminal kinase signaling pathway via S-nitrosylation contributes to ischemia neuronal death. Neuroscience 2008 155 4 1120 1132 2-s2.0-50249133181 10.1016/j.neuroscience.2008.03.061
66. Eliasson M. J. L., Huang Z., Ferrante R. J., Sasamata M., Molliver M. E., Snyder S. H., Moskowitz M. A., Neuronal nitric oxide synthase activation and peroxynitrite formation in ischemic stroke linked to neural damage. The Journal of Neuroscience 1999 19 14 5910 5918 2-s2.0-0033565586 (Pubitemid 29327926)
67. Gürsoy-Ozdemir Y., Can A., Dalkara T., Reperfusion-induced oxidative/nitrative injury to neurovascular unit after focal cerebral ischemia. Stroke 2004 35 6 1449 1453 (Pubitemid 38697474)
68. Danielisova V., Burda J., Nemethova M., Gottlieb M., Aminoguanidine administration ameliorates hippocampal damage after middle cerebral artery occlusion in rat. Neurochemical Research 2011 36 3 476 486 2-s2.0-79954420117 10.1007/s11064-010-0366-1
69. Trickler W. J., Mayhan W. G., Miller D. W., Brain microvessel endothelial cell responses to tumor necrosis factor-alpha involve a nuclear factor kappa B (NF- B) signal transduction pathway. Brain Research 2005 1048 1-2 24 31 2-s2.0-20444398140 10.1016/j.brainres.2005.04.028 (Pubitemid 40800256)
70. Katsuyama K., Shichiri M., Marumo F., Hirata Y., NO inhibits cytokine-induced iNOS expression and NF- B activation by interfering with phosphorylation and degradation of I B- α Arteriosclerosis, Thrombosis, and Vascular Biology 1998 18 11 1796 1802 2-s2.0-0031794430 (Pubitemid 28521071)
71. Foncea R., Carvajal C., Almarza C., Leighton F., Endothelial cell oxidative stress and signal transduction. Biological Research 2000 33 2 89 96 2-s2.0-0347252674
72. ArunaDevi R., Ramteke V. D., Kumar S., Shukla M. K., Jaganathan S., Kumar D., Sharma A. K., Tandan S. K., Neuroprotective effect of s-methylisothiourea in transient focal cerebral ischemia in rat. Nitric Oxide 2010 22 1 1 10 2-s2.0-73149104144 10.1016/j.niox.2009.10.002
73. Samdani A. F., Dawson T. M., Dawson V. L., Nitric oxide synthase in models of focal ischemia. Stroke 1997 28 6 1283 1288 2-s2.0-0030988138 (Pubitemid 27248908)
74. Jackson-Lewis V., Smeyne R. J., MPTP and SNpc DA neuronal vulnerability: role of dopamine, superoxide and nitric oxide in neurotoxicity. Neurotoxicity Research 2005 7 3 193 201 2-s2.0-21744440118 10.1007/BF03036449
75. Marchetti B., Serra P. A., Tirolo C., L'Episcopo F., Caniglia S., Gennuso F., Testa N., Miele E., Desole S., Barden N., Morale M. C., Glucocorticoid receptor-nitric oxide crosstalk and vulnerability to experimental parkinsonism: pivotal role for glia-neuron interactions. Brain Research Reviews 2005 48 2 302 321 2-s2.0-20244369883 10.1016/j.brainresrev.2004.12.030 (Pubitemid 40585761)
76. Aliev G., Palacios H. H., Lipsitt A. E., Fischbach K., Lamb B. T., Obrenovich M. E., Morales L., Gasimov E., Bragin V., Nitric oxide as an initiator of brain lesions during the development of Alzheimer disease. Neurotoxicity Research 2009 16 3 293 305 2-s2.0-70349969737 10.1007/s12640-009- 9066-5
77. Malinski T., Nitric oxide and nitroxidative stress in Alzheimer's disease. Journal of Alzheimer's Disease 2007 11 2 207 218 2-s2.0-34347383021 (Pubitemid 47018067)
78. Simic G., Lucassen P. J., Krsnik Ž., Krušlin B., Kostović I., Winblad B., Bogdanović N., nNOS expression in reactive astrocytes correlates with increased cell death related DNA damage in the hippocampus and entorhinal cortex in Alzheimer's disease. Experimental Neurology 2000 165 1 12 26 2-s2.0-0033834306 10.1006/exnr.2000.7448
79. Jeynes B., Provias J., Significant negative correlations between capillary expressed eNOS and Alzheimer lesion burden. Neuroscience Letters 2009 463 3 244 248 2-s2.0-68949202838 10.1016/j.neulet.2009.07.091
80. Zhang F., White J. G., Iadecola C., Nitric oxide donors increase blood flow and reduce brain damage in focal ischemia: evidence that nitric oxide is beneficial in the early stages of cerebral ischemia. Journal of Cerebral Blood Flow and Metabolism 1994 14 2 217 226 2-s2.0-0028140030 (Pubitemid 24064434)
81. Zhang F., Xu S., Iadecola C., Time dependence of effect of nitric oxide synthase inhibition on cerebral ischemic damage. Journal of Cerebral Blood Flow and Metabolism 1995 15 4 595 601 2-s2.0-0029034598
82. Willmot M. R., Bath P. M. W., The potential of nitric oxide therapeutics in stroke. Expert Opinion on Investigational Drugs 2003 12 3 455 470 2-s2.0-0037340783 10.1517/13543784.12.3.455 (Pubitemid 36336415)
83. Miller M. R., Megson I. L., Recent developments in nitric oxide donor drugs. British Journal of Pharmacology 2007 151 3 305 321 2-s2.0-34249683823 10.1038/sj.bjp.0707224 (Pubitemid 46842668)
84. Scatena R., Bottoni P., Pontoglio A., Giardina B., Pharmacological modulation of nitric oxide release: new pharmacological perspectives, potential benefits and risks. Current Medicinal Chemistry 2010 17 1 61 73 2-s2.0-77249178254 10.2174/092986710789957841
85. Zhuang P., Ji H., Zhang Y. H., Min Z. L., Ni Q. G., You R., ZJM-289, a novel nitric oxide donor, alleviates the cerebral ischaemic-reperfusion injury in rats. Clinical and Experimental Pharmacology and Physiology 2010 37 3 e121 e127 2-s2.0-77649144513 10.1111/j.1440-1681.2010.05353.x
86. Jung K. H., Chu K., Lee S. T., Park H. K., Kim J. H., Kang K. M., Kim M., Lee S. K., Roh J. K., Augmentation of nitrite therapy in cerebral ischemia by NMDA receptor inhibition. Biochemical and Biophysical Research Communications 2009 378 3 507 512 2-s2.0-57749170753 10.1016/j.bbrc.2008.11.081
87. Salom J. B., Ortí M., Centeno J. M., Torregrosa G., Alborch E., Reduction of infarct size by the NO donors sodium nitroprusside and spermine/NO after transient focal cerebral ischemia in rats. Brain Research 2000 865 2 149 156 2-s2.0-0034717216 10.1016/S0006-8993(00)02095-3 (Pubitemid 30255992)
88. Coert B. A., Anderson R. E., Meyer F. B., Effects of the nitric oxide donor 3-morpholinosydnonimine (SIN-1) in focal cerebral ischemia dependent on intracellular brain pH. Journal of Neurosurgery 2002 97 4 914 921 2-s2.0-0036801580 (Pubitemid 35222415)
89. Zhang F., Iadecola C., Reduction of focal cerebral ischemic damage by delayed treatment with nitric oxide donors. Journal of Cerebral Blood Flow and Metabolism 1994 14 4 574 580 2-s2.0-0028244841 (Pubitemid 24198399)
90. Pluta R. M., Rak R., Wink D. A., Woodward J. J., Khaldi A., Oldfield E. H., Watson J. C., Effects of nitric oxide on reactive oxygen species production and infarction size after brain reperfusion injury. Neurosurgery 2001 48 4 884 893 2-s2.0-0035061658 (Pubitemid 32268098)
91. Salom J. B., Barberá M. D., Centeno J. M., Ortí M., Torregrosa G., Alborch E., Relaxant effects of sodium nitroprusside and NONOates in goat middle cerebral artery: delayed impairment by global ischemia-reperfusion. Nitric Oxide 1999 3 1 85 93 2-s2.0-0032807627 10.1006/niox.1999.0212 (Pubitemid 29393472)
92. Yamamoto T., Bing R. J., Nitric oxide donors. Proceedings of the Society for Experimental Biology and Medicine 2000 225 3 200 206 2-s2.0-0034521839 10.1046/j.1525-1373.2000.22525.x (Pubitemid 32041500)
93. Thatcher G. R. J., Nicolescu A. C., Bennett B. M., Toader V., Nitrates and no release: contemporary aspects in biological and medicinal chemistry. Free Radical Biology & Medicine 2004 37 8 1122 1143 2-s2.0-4644231576 10.1016/j.freeradbiomed.2004.06.013 (Pubitemid 39302540)
94. Granik V. G., Grigor'ev N. B., Exogenous donors of nitric oxide (a chemical aspect). Russian Chemical Bulletin 2002 51 8 1375 1422 2-s2.0-0141499015 10.1023/A:1020994402835 (Pubitemid 37115451)
95. Hogg N., The biochemistry and physiology of S-nitrosothiols. Annual Review of Pharmacology and Toxicology 2002 42 585 600 2-s2.0-0036174890 10.1146/annurev.pharmtox.42.092501.104328 (Pubitemid 34160536)
96. Hogg N., Darley-Usmar V. M., Wilson M. T., Moncada S., Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide. Biochemical Journal 1992 281 2 419 424 2-s2.0-0026500329
97. Dawson V. L., Dawson T. M., London E. D., Bredt D. S., Snyder S. H., Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proceedings of the National Academy of Sciences of the United States of America 1991 88 14 6368 6371 2-s2.0-0025773785 (Pubitemid 21914947)
98. Yamada M., Momose K., Richelson E., Yamada M., Sodium nitroprusside-induced apoptotic cellular death via production of hydrogen peroxide in murine neuroblastoma N1E-115 cells. Journal of Pharmacological and Toxicological Methods 1996 35 1 11 17 2-s2.0-0030002003 10.1016/1056-8719(95) 00111-5 (Pubitemid 26081986)
99. Terwel D., Nieland L. J. M., Schutte B., Reutelingsperger C. P. M., Ramaekers F. C. S., Steinbusch H. W. M., S-nitroso-N-acetylpenicillamine and nitroprusside induce apoptosis in a neuronal cell line by the production of different reactive molecules. European Journal of Pharmacology 2000 400 1 19 33 2-s2.0-0034648089 10.1016/S0014-2999(00)00379-4 (Pubitemid 30412105)
100. Cardaci S., Filomeni G., Rotilio G., Ciriolo M. R., Reactive oxygen species mediate p53 activation and apoptosis induced by sodium nitroprusside in SH-SY5Y cells. Molecular Pharmacology 2008 74 5 1234 1245 2-s2.0-54349110084 10.1124/mol.108.048975
101. Kim H. J., Tsoy I., Park M. K., Iron released by sodium nitroprusside contributes to heme oxygenase-1 induction via the cAMP-protein kinase A-mitogen-activated protein kinase pathway in RAW 264.7 cells. Molecular Pharmacology 2006 69 5 1633 1640 2-s2.0-33645820618 10.1124/mol.105.020487
102. Ignjatović D., Vojnović Milutinović D., Nikolić-Kokić A., The mechanisms responsible for neuroprotective capacity of arylpiperazine dopaminergic ligands against cell death induced by sodium nitroprusside. European Journal of Pharmacology 2012 683 1-3 93 100
103. Gomez-Sarosi L. A., Strasberg-Rieber M., Rieber M., ERK activation increases nitroprusside induced apoptosis in human melanoma cells irrespective of p53 status: role of superoxide dismutases. Cancer Biology and Therapy 2009 8 12 1173 1182 2-s2.0-68049147524
104. Matsuzaki H., Tamatani M., Mitsuda N., Namikawa K., Kiyama H., Miyake S. I., Tohyama M., Activation of Akt kinase inhibits apoptosis and changes in Bcl-2 and Bax expression induced by nitric oxide in primary hippocampal neurons. Journal of Neurochemistry 1999 73 5 2037 2046 2-s2.0-0032742675 (Pubitemid 29491818)
105. Gepdiremen A., Hacimüftüoǧlu A., Büyü kokuroǧlu M. E., Süleyman H., Nitric oxide donor sodium nitroprusside induces neurotoxicity in cerebellar granular cell culture in rats by an independent mechanism fromL-type or dantrolene-sensitive calcium channels. Biological & Pharmaceutical Bulletin 2002 25 10 1295 1297 (Pubitemid 39663188)
106. Bielarczyk H., Gul S., Ronowska A., Bizon-Zygmanska D., Pawelczyk T., Szutowicz A., RS- α -lipoic acid protects cholinergic cells against sodium nitroprusside and amyloid- β neurotoxicity through restoration of acetyl-CoA level. Journal of Neurochemistry 2006 98 4 1242 1251 2-s2.0-33746412987 10.1111/j.1471-4159.2006.03966.x (Pubitemid 44127798)
107. Zhang Y., Rosenberg P. A., Caspase-1 and poly (ADP-ribose) polymerase inhibitors may protect against peroxynitrite-induced neurotoxicity independent of their enzyme inhibitor activity. The European Journal of Neuroscience 2004 20 7 1727 1736 2-s2.0-8144223735 10.1111/j.1460-9568.2004.03651.x (Pubitemid 39471565)
108. Gray E., Ginty M., Kemp K., Scolding N., Wilkins A., Peroxisome proliferator-activated receptor- α agonists protect cortical neurons from inflammatory mediators and improve peroxisomal function. The European Journal of Neuroscience 2011 33 8 1421 1432 2-s2.0-79954531943 10.1111/j.1460-9568.2011. 07637.x
109. Blais V., Rivest S., Effects of TNF- α and IFN- γ on nitric oxide-induced neurotoxicity in the mouse brain. Journal of Immunology 2004 172 11 7043 7052 2-s2.0-2442685455 (Pubitemid 38669146)
110. Rauhala P., Khaldi A., Mohanakumar K. P., Chiueh C. C., Apparent role of hydroxyl radicals in oxidative brain injury induced by sodium nitroprusside. Free Radical Biology & Medicine 1998 24 7-8 1065 1073 2-s2.0-0032077132 10.1016/S0891-5849(97)00386-9 (Pubitemid 28246719)
111. Rabkin S. W., Kong J. Y., Nitroprusside induces cardiomyocyte death: interaction with hydrogen peroxide. The American Journal of Physiology 2000 279 6 H3089 H3100 2-s2.0-0034535476 (Pubitemid 32005900)
112. Mohanakumar K. P., Hanbauer I., Chiueh C. C., Neuroprotection by nitric oxide against hydroxyl radical-induced nigral neurotoxicity. Journal of Chemical Neuroanatomy 1998 14 3-4 195 205 2-s2.0-17544393549 10.1016/S0891-0618(98) 00032-5 (Pubitemid 28362422)
113. Rao D. N. R., Cederbaum A. I., Generation of reactive oxygen species by the redox cycling of nitroprusside. Biochimica et Biophysica Acta 1996 1289 2 195 202 2-s2.0-0343773381 10.1016/0304-4165(95)00158-1 (Pubitemid 26088678)
114. Belani K. G., Singh H., Beebe D. S., Cyanide toxicity in juvenile pigs and its reversal by a new prodrug, sulfanegen sodium. Anesthesia and Analgesia 2012 114 5 956 961
115. Chiueh C. C., Neurobiology of NO. and.OH: basic research and clinical relevance. Annals of the New York Academy of Sciences 1994 738 279 281 2-s2.0-0028610582
116. Chiueh C. C., Andoh T., Lai A. R., Lai E., Krishna G., Neuroprotective strategies in Parkinson's disease: protection against progressive nigral damage induced by free radicals. Neurotoxicity Research 2000 2 293 310
117. Mohanakumar K. P., Thomas B., Sharma S. M., Muralikrishnan D., Chowdhury R., Chiueh C. C., Nitric oxide: an antioxidant and neuroprotector. Annals of the New York Academy of Sciences 2002 962 389 401 2-s2.0-0036274895 (Pubitemid 34592327)
118. Rauhala P., Andoh T., Yeh K., Chiueh C. C., Contradictory effects of sodium nitroprusside and S-nitroso-N-acetylpenicillamine on oxidative stress in brain dopamine neurons in vivo. Annals of the New York Academy of Sciences 2002 962 60 72 2-s2.0-0036268267 (Pubitemid 34592300)
119. Heales S. J. R., Lam A. A. J., Duncan A. J., Land J. M., Neurodegeneration or neuroprotection: the pivotal role of astrocytes. Neurochemical Research 2004 29 3 513 519 2-s2.0-1542348215 10.1023/B:NERE. 0000014822.69384.0f (Pubitemid 38295002)
120. Banerjee R., Saravanan K. S., Thomas B., Sindhu K. M., Mohanakumar K. P., Evidence for hydroxyl radical scavenging action of nitric oxide donors in the protection against 1-methyl-4-phenylpyridinium-induced neurotoxicity in rats. Neurochemical Research 2008 33 6 985 995 2-s2.0-42149116437 10.1007/s11064-007- 9473-z
121. Hogg N., Kalyanaraman B., Joseph J., Struck A., Parthasarathy S., Inhibition of low-density lipoprotein oxidation by nitric oxide. Potential role in atherogenesis. FEBS Letters 1993 334 2 170 174 2-s2.0-0027527402 10.1016/0014-5793(93)81706-6 (Pubitemid 23330576)
122. Rauhala P., Mohanakumar K. P., Sziraki I., Lin A. M., Chiueh C. C., S-Nitrosothiols and nitric oxide, but not sodium nitroprusside, protect nigrostriatal dopamine neurons against iron-induced oxidative stress in vivo. Synapse 1996 23 1 58 60 (Pubitemid 26139973)
123. Tsai M. J., Lee E. H. Y., Nitric oxide donors protect cultured rat astrocytes from 1-methyl-4- phenylpyridinium-induced toxicity. Free Radical Biology & Medicine 1998 24 5 705 713 2-s2.0-0032521385 10.1016/S0891- 5849(97)00329-8 (Pubitemid 28169556)
124. Genc S., Kuralay F., Genc K., Akhisaroglu M., Fadiloglu S., Yorukoglu K., Fadiloglu M., Gure A., Erythropoietin exerts neuroprotection in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57/BL mice via increasing nitric oxide production. Neuroscience Letters 2001 298 2 139 141 2-s2.0-0035793485 10.1016/S0304-3940(00)01716-X (Pubitemid 32037074)
125. Wink D. A., Hanbauer I., Krishna M. C., DeGraff W., Gamson J., Mitchell J. B., Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proceedings of the National Academy of Sciences of the United States of America 1993 90 21 9813 9817 2-s2.0-0027381424 10.1073/pnas.90.21.9813 (Pubitemid 23328200)
126. Suschek C. V., Briviba K., Bruch-Gerharz D., Sies H., Kröncke K. D., Kolb-Bachofen V., Even after UVA-exposure will nitric oxide protect cells from reactive oxygen intermediate-mediated apoptosis and necrosis. Cell Death and Differentiation 2001 8 5 515 527 2-s2.0-0035019198 10.1038/sj.cdd.4400839 (Pubitemid 32492772)
127. Wenk G. L., McGann-Gramling K., Hauss-Wegrzyniak B., Ronchetti D., Maucci R., Rosi S., Gasparini L., Ongini E., Attenuation of chronic neuroinflammation by a nitric oxide-releasing derivative of the antioxidant ferulic acid. Journal of Neurochemistry 2004 89 2 484 493 2-s2.0-1942519702 10.1111/j.1471-4159.2004. 02359.x (Pubitemid 38495996)
128. Palumbo M. L., Fosser N. S., Rios H., Zubilete M. A. Z., Guelman L. R., Cremaschi G. A., Genaro A. M., Loss of hippocampal neuronal nitric oxide synthase contributes to the stress-related deficit in learning and memory. Journal of Neurochemistry 2007 102 1 261 274 2-s2.0-34250194666 10.1111/j.1471-4159.2007.04528.x (Pubitemid 46906266)
129. Contestabile A., Ciani E., Role of nitric oxide in the regulation of neuronal proliferation, survival and differentiation. Neurochemistry International 2004 45 6 903 914 2-s2.0-4243131409 10.1016/j.neuint.2004.03.021 (Pubitemid 39108063)
130. Zhang R., Zhang L., Zhang Z., Wang Y., Lu M., LaPointe M., Chopp M., A
131. Endres M., Gertz K., Lindauer U., Mechanisms of stroke protection by physical activity. Annals of Neurology 2003 54 5 582 590 (Pubitemid 37346064)
132. Hashiguchi A., Yano S., Morioka M., Hamada J., Ushio Y., Takeuchi Y., Fukunaga K., Up-regulation of endothelia nitric oxide synthase via phosphatidylinositol 3-kinase pathway contributes to ischemic tolerance in the CA1 subfield of the gerbil hippocampus. Journal of Cerebral Blood Flow and Metabolism 2004 24 3 271 279 2-s2.0-1542376872 (Pubitemid 38314583)
133. Lu D., Mahmood A., Zhang R., Copp M., Upregulation of neurogensis and reduction in functional deficits following administration of DEtA/NONOate, a nitric oxide donor, after traumatic brain injury in rats. Journal of Neurosurgery 2003 99 2 351 361 (Pubitemid 36900130)
134. Khan M., Im Y. B., Shunmugavel A., Gilg A. G., Dhindsa R. K., Singh A. K., Singh I., Administration of S-nitrosoglutathione after traumatic brain injury protects the neurovascular unit and reduces secondary injury in a rat model of controlled cortical impact. Journal of Neuroinflammation 2009 6, article 32 2-s2.0-70749156375 10.1186/1742-2094-6-32
135. Puzzo D., Vitolo O., Trinchese F., Jacob J. P., Palmeri A., Arancio O., Amyloid- β peptide inhibits activation of the nitric oxide/cGMP/cAMP- responsive element-binding protein pathway during hippocampal synaptic plasticity. The Journal of Neuroscience 2005 25 29 6887 6897 2-s2.0-22544485048 10.1523/JNEUROSCI.5291-04.2005 (Pubitemid 41023156)
136. Hua Y., Huang X. Y., Zhou L., DETA/NONOate, a nitric oxide donor, produces antidepressant effects by promoting hippocampal neurogenesis. Psychopharmacology 2008 200 2 231 242
137. Gertz K., Endres M., eNOS and stroke: prevention, treatment and recovery. Future Neurology 2008 3 5 537 550 2-s2.0-55649090046 10.2217/14796708.3.5.537
138. Yilmaz G., Granger D. N., Cell adhesion molecules and ischemic stroke. Neurological Research 2008 30 8 783 793 2-s2.0-53549132254 10.1179/ 174313208X341085
139. Yasuda Y., Shimoda T., Uno K., Tateishi N., Furuya S., Tsuchihashi Y., Kawai Y., Naruse S., Fujita S., Temporal and sequential changes of glial cells and cytokine expression during neuronal degeneration after transient global ischemia in rats. Journal of Neuroinflammation 2011 8, article 70 2-s2.0-79959362175 10.1186/1742-2094-8-70
140. Prasad R., Giri S., Nath N., Singh I., Singh A. K., GSNO attenuates EAE disease by S-nitrosylation-mediated modulation of endothelial-monocyte interactions. GLIA 2007 55 1 65 77 2-s2.0-33751559370 10.1002/glia.20436 (Pubitemid 44845510)
141. Massoudy P., Zahler S., Freyholdt T., Henze R., Barankay A., Becker B. F., Braun S. L., Meisner H., Sodium nitroprusside in patients with compromised left ventricular function undergoing coronary bypass: reduction of cardiac proinflammatory substances. Journal of Thoracic and Cardiovascular Surgery 2000 119 3 566 574 2-s2.0-0034104396 (Pubitemid 30146537)
142. Göl M. K., Nisanoǧlu V., Işcan Z., Balci M., Kandemir O., Taşdemir O., Inhibition of systemic inflammatory response with sodium nitroprusside in open heart surgery. Journal of Cardiovascular Surgery 2002 43 6 803 809 (Pubitemid 36040812)
143. Freyholdt T., Massoudy P., Zahler S., Henze R., Barankay A., Becker B. F., Meisner H., Beneficial effect of sodium nitroprusside after coronary artery bypass surgery: pump function correlates inversely with cardiac release of proinflammatory cytokines. Journal of Cardiovascular Pharmacology 2003 42 3 372 378 2-s2.0-0041336968 10.1097/00005344-200309000-00008 (Pubitemid 37071693)
144. Sánchez-Pérez-Verdía E., López-Neblina F., Portilla E., Ortíz G. G., González-Ojeda A., Álvares R., Exogenous nitric oxide protects kidney from ischemia/reperfusion. Journal of Investigative Surgery 2001 14 6 313 320 (Pubitemid 34229002)
145. Anaya-Prado R., Toledo-Pereyra L. H., Walsh J., Guo R. F., Reuben J., Ward P. A., Exogenous nitric oxide donor and related compounds protect against lung inflammatory response after hemorrhagic shock and resuscitation. Journal of Trauma 2004 57 5 980 988 2-s2.0-9644252670 10.1097/01.TA.0000135354.72494.8D (Pubitemid 39579281)
146. Clemens J. A., Stephenson D. T., Dixon E. P., Smalstig E. B., Mincy R. E., Rash K. S., Little S. P., Global cerebral ischemia activates nuclear factor- KB prior to evidence of DNA fragmentation. Molecular Brain Research 1997 48 2 187 196 2-s2.0-0030766036 10.1016/S0169-328X(97)00092-2 (Pubitemid 27390055)
147. Zhang W., Potrovita I., Tarabin V., Herrmann O., Beer V., Weih F., Schneider A., Schwaninger M., Neuronal activation of NF- B contributes to cell death in cerebral ischemia. Journal of Cerebral Blood Flow and Metabolism 2005 25 1 30 40 2-s2.0-11844269946 10.1038/sj.jcbfm.9600004 (Pubitemid 40096895)
148. Howard E. F., Chen Q., Cheng C., Carroll J. E., Hess D., NF- B is activated and ICAM-1 gene expression is upregulated during reoxygenation of human brain endothelial cells. Neuroscience Letters 1998 248 3 199 203 2-s2.0-0032486242 10.1016/S0304-3940(98)00239-0 (Pubitemid 28281389)
149. 2 as a trigger and NF- B as a signal transducer. Thrombosis and Haemostasis 2003 90 3 528 537 2-s2.0-0141540646 (Pubitemid 37138779)
150. Bhakar A. L., Tannis L. L., Zeindler C., Russo M. P., Jobin C., Park D. S., MacPherson S., Barker P. A., Constitutive nuclear factor- B activity is required for central neuron survival. The Journal of Neuroscience 2002 22 19 8466 8475 2-s2.0-0036813662 (Pubitemid 35387587)
151. Sarkar F. H., Li Y., Wang Z., Kong D., NF- B signaling pathway and its therapeutic implications in human diseases. International Reviews of Immunology 2008 27 5 293 319 2-s2.0-53949090765 10.1080/08830180802276179
152. Sarnico I., Lanzillotta A., Boroni F., Benarese M., Alghisi M., Schwaninger M., Inta I., Battistin L., Spano P., Pizzi M., NF- B p50/RelA and c-Rel-containing dimers: opposite regulators of neuron vulnerability to ischaemia. Journal of Neurochemistry 2009 108 2 475 485 2-s2.0-57549112366 10.1111/j.1471-4159.2008.05783.x
153. Stephenson D., Yin T., Smalstig E. B., Hsu M. A., Panetta J., Little S., Clemens J., Transcription factor nuclear factor-kappa B is activated in neurons after focal cerebral ischemia. Journal of Cerebral Blood Flow and Metabolism 2000 20 3 592 603 2-s2.0-0034061930 (Pubitemid 30164903)
154. Ridder D. A., Schwaninger M., NF- B signaling in cerebral ischemia. Neuroscience 2009 158 3 995 1006 2-s2.0-59349107204 10.1016/j.neuroscience.2008. 07.007
155. Cummins E. P., Berra E., Comerford K. M., Ginouves A., Fitzgerald K. T., Seeballuck F., Godson C., Nielsen J. E., Moynagh P., Pouyssegur J., Taylor C. T., Prolyl hydroxylase-1 negatively regulates I B kinase- β giving insight into hypoxia-induced NF B activity. Proceedings of the National Academy of Sciences of the United States of America 2006 103 48 18154 18159 2-s2.0-33845321931 10.1073/pnas.0602235103 (Pubitemid 44871628)
156. Blais V., Rivest S., Inhibitory action of nitric oxide on circulating tumor necrosis factor-induced NF- B activity and COX-2 transcription in the endothelium of the brain capillaries. Journal of Neuropathology and Experimental Neurology 2001 60 9 893 905 2-s2.0-0034821241 (Pubitemid 32880597)
157. Huang C. Y., Fujimura M., Noshita N., Chang Y. Y., Chan P. H., SOD1 down-regulates NF- B and c-Myc expression in mice after transient focal cerebral ischemia. Journal of Cerebral Blood Flow and Metabolism 2001 21 2 163 173 2-s2.0-0035122043 (Pubitemid 32143978)
158. Guerrini L., Blasi F., Denis-Donini S., Synaptic activation of NF- B by glutamate in cerebellar granule neurons in vitro. Proceedings of the National Academy of Sciences of the United States of America 1995 92 20 9077 9081 2-s2.0-0028981287 10.1073/pnas.92.20.9077
159. Greco R., Mangione A. S., Amantea D., Bagetta G., Nappi G., Tassorelli C., IkappaB-alpha expression following transient focal cerebral ischemia is modulated by nitric oxide. Brain Research 2011 1372 145 151 2-s2.0-79151477027 10.1016/j.brainres.2010.11.071
160. Gabriel C., Justicia C., Camins A., Planas A. M., Activation of nuclear factor- -B in the rat brain after transient focal ischemia. Molecular Brain Research 1999 65 1 61 69 2-s2.0-0033582761 10.1016/S0169-328X(98)00330-1 (Pubitemid 29138679)
161. Peng H. B., Libby P., Liao J. K., Induction and stabilization of I B α by nitric oxide mediates inhibition of NF- B. The Journal of Biological Chemistry 1995 270 23 14214 14219 2-s2.0-0029011129 10.1074/jbc.270.23.14214
162. de Caterina R., Libby P., Peng H. B., Thannickal V. J., Rajavashisth T. B., Gimbrone M., Wee Soo Shin, Liao J. K., Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. The Journal of Clinical Investigation 1995 96 1 60 68 2-s2.0-0029159779
163. Walley K. R., McDonald T. E., Higashimoto Y., Hayashi S., Modulation of proinflammatory cytokines by nitric oxide in murine acute lung injury. American Journal of Respiratory and Critical Care Medicine 1999 160 2 698 704 2-s2.0-0032814499 (Pubitemid 29380692)
164. Park S. W., Huq M. D. M., Hu X., Wei L. N., Tyrosine nitration on p65: a novel mechanism to rapidly inactive nuclear factor- B. Molecular and Cellular Proteomics 2005 4 3 300 309 2-s2.0-15944409156 10.1074/mcp.M400195-MCP200 (Pubitemid 40439773)
165. Song Y. S., Kim M. S., Kim H. A., Jung B. I., Yang J., Narasimhan P., Kim G. S., Jung J. E., Park E. H., Chan P. H., Oxidative stress increases phosphorylation of IB kinase- α by enhancing NF- B-inducing kinase after transient focal cerebral ischemia. Journal of Cerebral Blood Flow and Metabolism 2010 30 7 1265 1274 2-s2.0-77954244631 10.1038/jcbfm.2010.6
166. Candelario-Jalil E., González-Falcón A., García-Cabrera M., Álvarez D., Al-Dalain S., Martínez G., León O. S., Springer J. E., Assessment of the relative contribution of COX-1 and COX-2 isoforms to ischemia-induced oxidative damage and neurodegeneration following transient global cerebral ischemia. Journal of Neurochemistry 2003 86 3 545 555 2-s2.0-0041302369 10.1046/j.1471-4159.2003. 01812.x (Pubitemid 36897435)
167. Candelario-Jalil E., Alvarez D., Merino N., León O. S., Delayed treatment with nimesulide reduces measures of oxidative stress following global ischemic brain injury in gerbils. Neuroscience Research 2003 47 2 245 253 2-s2.0-0141739581 10.1016/S0168-0102(03)00184-6 (Pubitemid 37152462)
168. Nakayama M., Uchimura K., Zhu R. L., Nagayama T., Rose M. E., Stetler R. A., Isakson P. C., Chen J., Graham S. H., Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia. Proceedings of the National Academy of Sciences of the United States of America 1998 95 18 10954 10959 2-s2.0-0032168376 10.1073/pnas.95.18.10954 (Pubitemid 28413175)
169. Ahmad M., Zhang Y., Liu H., Rose M. E., Graham S. H., Prolonged opportunity for neuroprotection in experimental stroke with selective blockade of cyclooxygenase-2 activity. Brain Research 2009 1279 168 173 2-s2.0-67649410136 10.1016/j.brainres.2009.05.020
170. Im J. Y., Kim D., Paik S. G., Han P. L., Cyclooxygenase-2-dependent neuronal death proceeds via superoxide anion generation. Free Radical Biology & Medicine 2006 41 6 960 972 2-s2.0-33747348720 10.1016/j.freeradbiomed. 2006.06.001 (Pubitemid 44247547)
171. Speed N., Blair A. I., Cyclooxygenase- and lipoxygenase-mediated DNA damage. Cancer Metastasis Reviews 2011 30 3-4 437 447
172. D'Acquisto F., Maiuri M. C., de Cristofaro F., Carnuccio R., Nitric oxide prevents inducible cyclooxygenase expression by inhibiting nuclear factor- B and nuclear factor-interleukin-6 activation. Naunyn-Schmiedeberg's Archives of Pharmacology 2001 364 2 157 165 2-s2.0-0034907601 10.1007/s002100100435 (Pubitemid 32706702)
173. Marshall H. E., Stamler J. S., Inhibition of NF- B by S-nitrosylation. Biochemistry 2001 40 6 1688 1693 2-s2.0-0035852845 10.1021/bi002239y (Pubitemid 32144038)
174. Reynaert N. L., Ckless K., Korn S. H., Vos N., Guala A. S., Wouters E. F. M., Van Der Vliet A., Janssen-Heininger Y. M. W., Nitric oxide represses inhibitory B kinase through S-nitrosylation. Proceedings of the National Academy of Sciences of the United States of America 2004 101 24 8945 8950 2-s2.0-2942695715 10.1073/pnas.0400588101 (Pubitemid 38781591)
175. Hall C. N., Garthwaite J., What is the real physiological NO concentration in vivo? Nitric Oxide 2009 21 2 92 103 2-s2.0-68149169007 10.1016/j.niox.2009.07.002